Abstract
Aim
To determine the number of annual hospital discharges for inflammatory bowel diseases in Chile. The hypothesis is that there is a significant increase in the hospital discharges due to this disease from 2001 to 2012.
Materials and Methods
This is a descriptive study. Data were obtained from the Web site of the Department of Health Statistics. All hospital discharges from 2001 to 2012 were included. The following variables were analyzed: length of stay, hospital mortality, and eventual surgical procedure. Data are presented as descriptive statistics. The B-coefficient was calculated to establish the significance of the annual trend.
Results
There were 13,001 hospital discharges with the diagnosis of ulcerative colitis or Crohn’s disease, corresponding to 0.067% of all hospital discharges in the whole period. Within these discharges, 31.2% were Crohn’s disease and 68.8% were ulcerative colitis. At least one surgical procedure was performed in 12.9% of the hospitalizations. There was a significant increase in the annual rate of hospital discharges from 5.25 in 2001 to 8.64 per 100 thousand inhabitants in 2012. This increase was from 1.68 to 3.11 in Crohn’s disease and from 3.58 to 5.53 in ulcerative colitis. However, a decrease was observed in length of stay, need of surgical treatment and in-hospital mortality.
Conclusion
From 2001 until 2012, there has been a significant increase in hospital discharges for inflammatory bowel diseases in Chile, associated with a decrease in length of stay, need of surgery and in-hospital mortality.
Similar content being viewed by others
References
Hwang J, Varma M. Surgery for inflammatory bowel disease. World J Gastroenterol. 2008;14:2678–2690.
Nguyen G, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007;13:1529–1535.
Lakatos P. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006;12:6102–6108.
Jakubowski A, Zagorowicz E, Kraszewska E, et al. Rising hospitalization rates for inflammatory bowel disease in Poland. Pol Arch Med Wewn. 2014;124:180–190.
Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274–1282.
Smyth C, Bacheer S, Rathore O, et al. Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996–2001. Ir J Med Sci. 2005;174:28–32.
Benchimol E, Mack D, Guttman A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol. 2015;110:553–563.
Bewtra M, Su C, Lewis J. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2007;5:597–601.
Figueroa C, Quera R, Valenzuela J, et al. Inflammatory bowel disease: experience of two Chilean centers. Rev Med Chile. 2005;133:1295–1304.
Simian D, Fluxa D, Flores L, et al. inflammatory bowel disease: a descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016;22:5267–5275.
Rautava S, Ruuskanen O, Ouwehand A, et al. The hygiene hypothesis of atopic disease an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378–388.
Bloomfield S, Rook G, Scott E, et al. Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health. 2016;136:213–224.
Luque C, Cisternas F, Araya M. Cambios del patrón de enfermedad en la postransición epidemiológica en salud en Chile, 1950–2003. Rev Med Chile. 2006;134:703–712.
Raval M, Schnitzler M, O’Connor B, et al. Improved outcome due to increased experience and individualized management of leaks after ileal pouch-anal anastomosis. Ann Surg. 2007;246:763–770.
Fazio V, Tekkis P, Remzi F, et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg. 2003;238:605–617.
Sakatani A, Fujiya M, Ito T, et al. Infliximab extends the duration until the first surgery in patients with Crohn’s disease. Biomed Res Int 2013;2013 Article ID 879491.
Sokol H, Seksik P, Cosnes J. Complications and surgery in the inflammatory bowel diseases biological era. Curr Opin Gastroenterol. 2014;30:378–384.
Devaraj B, Kaiser A. Surgical management of ulcerative colitis in the era of biologicals. Inflamm Bowel Dis. 2015;21:208–220.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Felipe Bellolio Roth, Javier Gómez and Jaime Cerda have no conflicts of interest of any kind.
Rights and permissions
About this article
Cite this article
Bellolio Roth, F., Gómez, J. & Cerda, J. Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012. Dig Dis Sci 62, 2311–2317 (2017). https://doi.org/10.1007/s10620-017-4660-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-017-4660-5